Watch these 22 stocks: Pharma majors, Tata group, SBI, Kotak Mahindra Bank, Varroc, Thomas Cook, Vikram Solar
Generic semaglutide launches by multiple drugmakers dominate pharma action, while SBI faces a hefty tax demand. Kotak Mahindra Bank, Tata group firms, Wipro, Infosys, and others drive dealmaking, AI, expansion and order activity.
Generic semaglutide launches by multiple drugmakers dominate pharma action, while SBI faces a hefty tax demand. Kotak Mahindra Bank, Tata group firms, Wipro, Infosys, and others drive dealmaking, AI, expansion and order activity.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
